Brief: Biomx Reports Fourth Quarter And Full Year 2022 Financial Results

March 29 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * BIOMX INC - CASH RUNWAY THROUGH AT LEAST MID-2024
    * BIOMX INC - PATIENT ENROLLMENT CONTINUES IN PART 2 OF
PHASE
1B/2A TRIAL WITH RESULTS EXPECTED IN Q3 OF 2023
    * BIOMX INC - ANNOUNCED POSITIVE RESULTS FROM PART 1 OF
ONGOING
PHASE 1B/2A TRIAL OF BX004 FOR TREATMENT OF LUNG INFECTIONS IN
CYSTIC FIBROSIS ("CF")
    * BIOMX INC - CASH BALANCE, SHORT-TERM DEPOSITS AND
RESTRICTED
CASH AS OF DECEMBER 31, 2022, WERE $34.3 MILLION

Source text for Eikon:  ID:nGNX7bDTxw 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biomx

See all news